Innovating Works
IB4SD-TRISTAN: Imaging Biomarkers IBs for Safer Drugs Validation of Translational Imaging Methods in Drug Safety... EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL tramitó un H2020: H2020-JTI-IMI2-2015-07-two-stage 1.Our consortium has broad, deep experience of drug development and imaging biomarker (IB) validation. We are internationally recognized exp...
2017-03-10 - 2024-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.